BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17609392)

  • 1. Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.
    Rajam G; Carlone GM; Romero-Steiner S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1223-7. PubMed ID: 17609392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.
    Spencer BL; Shenoy AT; Orihuela CJ; Nahm MH
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly.
    Ortqvist A; Henckaerts I; Hedlund J; Poolman J
    Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization.
    Licciardi PV; Balloch A; Russell FM; Mulholland EK; Tang ML
    Vaccine; 2010 May; 28(22):3793-800. PubMed ID: 20362199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M; Eklund C; Eskola J; Käyhty H
    J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A.
    Hao L; Kuttel MM; Ravenscroft N; Thompson A; Prasad AK; Gangolli S; Tan C; Cooper D; Watson W; Liberator P; Pride MW; Jansen KU; Anderson AS; Scully IL
    Vaccine; 2022 Aug; 40(33):4872-4880. PubMed ID: 35810060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.
    O'Brien KL; Moïsi J; Romero-Steiner S; Holder P; Carlone GM; Reid R; Santosham M
    Vaccine; 2009 Mar; 27(12):1863-8. PubMed ID: 19171175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
    Balmer P; Borrow R; Arkwright PD
    Vaccine; 2007 Aug; 25(34):6321-5. PubMed ID: 17629373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
    Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
    Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C.
    Kaur R; Gonzalez E; Pham M; Pichichero M
    Vaccine; 2023 Nov; 41(48):7265-7273. PubMed ID: 37925318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an ELISA using serotype-specific antigens from selected pneumococcal strains of own selection.
    Slotved HC; Jacobsen JN; Møller HK; Krogfelt KA
    Vaccine; 2007 Mar; 25(13):2513-7. PubMed ID: 17007972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of group 17 specific antibodies by pneumococcal type 17F and 17A polysaccharide vaccines.
    Frasch CE; Concepcion NF
    Biologicals; 2001 Mar; 29(1):11-6. PubMed ID: 11482888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.
    Poolman J; Kriz P; Feron C; Di-Paolo E; Henckaerts I; Miseur A; Wauters D; Prymula R; Schuerman L
    Vaccine; 2009 May; 27(24):3213-22. PubMed ID: 19446194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.